Konkurs w ramach Inicjatywy Leków Innowacyjnych 2
- Addressing the clinical burden of Clostridium difficile infection (CDI): Evaluation of the burden, current practices and set-up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
- Development of immune tolerance therapies for the treatment of rheumatic diseases
- Data quality in preclinical research and development
- Next generation of electronic translational safety
- Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD)
- Joint influenza vaccine effectiveness studies.
Tagi: leki, innowacje, konkurs
wstecz Podziel się ze znajomymi